TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
RCKT

Rocket Pharmaceuticals Inc

Healthcare · Biotechnology

2.60$ +1.5% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Rocket Pharmaceuticals Inc (RCKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 423 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCKT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
599 566 499 446 394 528 471 421 368 330 285 423
447 378 345 293 242 378 324 277 228 193 150 290
226 56 35 39 66 164 50 33 76 78 50 225
437 373 330 279 236 372 318 271 223 189 144 284
– – 8.6 8.1 – – – – – – – –
39 39 39 39 39 39 39 39 39 39 39 39
25 25 25 25 25 25 25 25 25 25 25 25
58 74 58 62 64 64 59 67 54 53 47 54
33 49 33 38 40 41 35 43 31 30 24 31
2.9 2.7 2.9 2.9 2.8 2.9 2.9 2.9 2.9 2.9 2.9 3.0
1.9 0.0 2.8 3.1 2.8 1.6 2.9 1.7 2.7 – 4.2 28
541 493 442 385 330 463 412 354 314 277 238 369
-900 -959 -1,021 -1,091 -1,158 -1,218 -1,279 -1,348 -1,399 -1,441 -1,489 -1,366
83 84 94 94 94 98 110 111 112 111 112 115

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?